SGX302

· Soligenix

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGX302, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Topical SGX302 for Mild-to-Moderate Psoriasis [Phase 2]